Fig. 7

The schematic diagram of targeting RIPK1 ameliorates pulmonary injury by modulating the function of neutrophils and vascular endothelial cells.
The schematic diagram of targeting RIPK1 ameliorates pulmonary injury by modulating the function of neutrophils and vascular endothelial cells.